MiR-634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo

Resistance to chemotherapy is one of the key causal factors in cancer death and increasing evidence has revealed that microRNAs (miRNAs) are involved in chemoresistance in many kinds of human cancers. Paclitaxel has been used for treatment of advanced nasopharyngeal carcinoma (NPC); however, treatme...

Full description

Saved in:
Bibliographic Details
Published in:Int J Clin Exp Pathol
Main Authors: Peng, Xiaowei, Cao, Peiguo, He, Dong, Han, Shuang, Zhou, Jianda, Tan, Guolin, Li, Wei, Yu, Fenghui, Yu, Jianjun, Li, Zan, Cao, Ke
Format: Artigo
Language:Inglês
Published: e-Century Publishing Corporation 2014
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4230079/
https://ncbi.nlm.nih.gov/pubmed/25400759
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items